Daniel J Rader Selected Research

HDL Cholesterol

11/2021	Assessing HDL Metabolism in Subjects with Elevated Levels of HDL Cholesterol and Coronary Artery Disease.
1/2020	Novel congenital disorder of O-linked glycosylation caused by GALNT2 loss of function.
1/2020	Correlates and Predictors of Cerebrospinal Fluid Cholesterol Efflux Capacity from Neural Cells, a Family of Biomarkers for Cholesterol Epidemiology in Alzheimer's Disease.
1/2020	Anti-Inflammatory HDL Function, Incident Cardiovascular Events, and Mortality: A Secondary Analysis of the JUPITER Randomized Clinical Trial.
1/2019	Associations between cardiovascular disease, cancer, and very low high-density lipoprotein cholesterol in the REasons for Geographical and Racial Differences in Stroke (REGARDS) study.
1/2018	High density lipoprotein cholesterol and cancer: Marker or causative?
1/2018	A Novel Generalized Lipodystrophy-Associated Progeroid Syndrome Due to Recurrent Heterozygous LMNA p.T10I Mutation.
11/2017	HDL Cholesterol Metabolism and the Risk of CHD: New Insights from Human Genetics.
10/2017	Large-Scale Analysis of Determinants, Stability, and Heritability of High-Density Lipoprotein Cholesterol Efflux Capacity.
9/2017	Paradoxical coronary artery disease in humans with hyperalphalipoproteinemia is associated with distinct differences in the high-density lipoprotein phosphosphingolipidome.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel J Rader Research Topics

Disease

103	Atherosclerosis 01/2022 - 05/2002
78	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 05/2002
57	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 03/2003
53	Coronary Disease (Coronary Heart Disease) 12/2018 - 01/2003
33	Inflammation (Inflammations) 11/2020 - 07/2002
27	Type 2 Diabetes Mellitus (MODY) 01/2021 - 08/2003
25	Insulin Resistance 01/2022 - 08/2003
22	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2018 - 08/2003
21	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2022 - 09/2002
21	Hypercholesterolemia 11/2019 - 01/2000
19	Obesity 01/2022 - 12/2002
19	Myocardial Infarction 10/2019 - 04/2004
17	COVID-19 09/2022 - 01/2020
17	Homozygous Familial Hypercholesterolemia 01/2021 - 03/2005
16	Dyslipidemias (Dyslipidemia) 01/2022 - 01/2003
13	Hypertriglyceridemia 01/2022 - 01/2000
10	Stroke (Strokes) 11/2021 - 02/2002
9	Heart Failure 01/2020 - 11/2013
9	Vascular Diseases (Vascular Disease) 01/2018 - 01/2000
8	Hyperlipidemias (Hyperlipidemia) 01/2022 - 08/2003
8	Weight Loss (Weight Reduction) 01/2022 - 05/2003
8	Neoplasms (Cancer) 12/2021 - 10/2012
8	Chronic Renal Insufficiency 01/2019 - 01/2008
8	Acute Coronary Syndrome 10/2018 - 04/2004
8	Hypertension (High Blood Pressure) 07/2015 - 03/2007
7	Thrombosis (Thrombus) 01/2019 - 01/2002
6	Non-alcoholic Fatty Liver Disease 01/2022 - 10/2015
6	Genetic Risk Score 01/2021 - 02/2016
6	Atherosclerotic Plaque (Atheroma) 10/2019 - 07/2005
5	Liver Diseases (Liver Disease) 01/2022 - 01/2017
5	Infections 04/2021 - 08/2010
5	Aortic Valve Stenosis (Aortic Stenosis) 01/2020 - 12/2016
5	Cardiomyopathies (Cardiomyopathy) 12/2019 - 06/2002
5	Endotoxemia 02/2012 - 11/2004
4	Kidney Diseases (Kidney Disease) 11/2021 - 07/2014
4	Inborn Genetic Diseases (Disease, Hereditary) 01/2020 - 01/2013
4	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2018 - 09/2012
4	Body Weight (Weight, Body) 03/2013 - 05/2003
3	Severe Acute Respiratory Syndrome 09/2022 - 07/2021
3	Overweight 01/2022 - 08/2012
3	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 11/2013
3	Heart Diseases (Heart Disease) 12/2021 - 01/2019
3	Peripheral Arterial Disease 01/2021 - 01/2020
3	Aortic Valve Disease 01/2020 - 01/2017
3	Unstable Angina 01/2020 - 04/2004
3	Abdominal Aortic Aneurysm 01/2020 - 03/2008

Drug/Important Bio-Agent (IBA)

78	LipidsIBA 01/2022 - 01/2000
66	HDL CholesterolIBA 11/2021 - 01/2000
57	CholesterolIBA 01/2022 - 02/2002
54	LDL CholesterolIBA 01/2022 - 11/2002
46	HDL LipoproteinsIBA 01/2021 - 01/2002
43	Lipoproteins (Lipoprotein)IBA 01/2022 - 01/2002
42	oxidized low density lipoproteinIBA 01/2022 - 02/2002
40	Triglycerides (Triacylglycerol)IBA 01/2022 - 03/2003
30	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2002
28	Apolipoprotein A-I (Apolipoprotein A1)IBA 10/2019 - 05/2002
27	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 02/2002
24	Biomarkers (Surrogate Marker)IBA 09/2022 - 01/2004
21	LDL Receptors (LDL Receptor)IBA 01/2019 - 09/2002
16	ApolipoproteinsIBA 01/2019 - 09/2002
13	Apolipoproteins B (ApoB)IBA 01/2021 - 03/2003
12	C-Reactive ProteinIBA 11/2016 - 10/2003
11	Lipoprotein(a)IBA 10/2018 - 08/2003
11	Lipase (Acid Lipase)FDA Link 03/2014 - 04/2003
10	Biological ProductsIBA 01/2022 - 01/2009
10	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021 - 03/2003
10	Apolipoproteins E (ApoE)IBA 12/2016 - 10/2005
9	Pharmaceutical PreparationsIBA 12/2021 - 01/2007
9	CytokinesIBA 02/2015 - 09/2002
7	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 02/2006
6	Insulin (Novolin)FDA Link 01/2022 - 11/2004
6	Interleukin-6 (Interleukin 6)IBA 11/2021 - 02/2005
6	EnzymesIBA 01/2020 - 06/2009
6	Niacin (Nicotinic Acid)FDA LinkGeneric 10/2018 - 08/2012
6	Apolipoproteins AIBA 01/2017 - 05/2006
6	BMS201038IBA 01/2017 - 01/2007
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2016 - 11/2004
6	Atorvastatin (Lipitor)FDA Link 09/2015 - 03/2003
5	AdiponectinIBA 01/2022 - 01/2006
5	AntibodiesIBA 04/2021 - 04/2016
5	Liver X ReceptorsIBA 01/2020 - 05/2005
5	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2007
5	Apoprotein(a) (Apolipoprotein (a))IBA 01/2017 - 05/2006
5	microsomal triglyceride transfer proteinIBA 01/2017 - 01/2007
5	CalciumIBA 11/2016 - 12/2008
5	Transcription Factors (Transcription Factor)IBA 01/2016 - 01/2006
5	Pravastatin (Pravachol)FDA LinkGeneric 09/2015 - 03/2003
5	AdipokinesIBA 09/2015 - 01/2006
4	Antiviral Agents (Antivirals)IBA 01/2022 - 07/2021
4	LeptinIBA 01/2018 - 08/2004
4	Proprotein Convertase 9IBA 01/2018 - 02/2014
4	sortilinIBA 01/2018 - 10/2014
4	Cholesterol Ester Transfer ProteinsIBA 06/2017 - 02/2003
4	ResistinIBA 09/2015 - 11/2004
4	LipopolysaccharidesIBA 06/2015 - 07/2002
4	Secretory Phospholipases A2IBA 11/2013 - 07/2002
4	PPAR alphaIBA 05/2010 - 07/2005
3	Angiotensin-Converting Enzyme 2IBA 09/2022 - 01/2022
3	InterferonsIBA 01/2022 - 01/2021

Therapy/Procedure

58	Therapeutics 09/2022 - 01/2000